title: COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.
abstract: Epidemiological and clinical studies suggest that non-steroidal anti-inflammatory drugs (NSAIDs), including cyclooxygenase (COX)-2 selective inhibitors, reduce the risk of developing cancer. Experimental studies in human cancer cell lines and rodent models of carcinogenesis support these observations by providing strong evidence for the antineoplastic properties of NSAIDs. The involvement of COX-2 in tumorigenesis and its overexpression in various cancer tissues suggest that inhibition of COX-2 is responsible for the chemopreventive efficacy of these agents. However, the precise mechanisms by which NSAIDs exert their antiproliferative effects are still a matter of debate. Numerous other studies have shown that NSAIDs can act through COX-independent mechanisms. This review provides a detailed description of the major COX-independent molecular targets of NSAIDs and discusses how these targets may be involved in their anticancer effects. Toxicities resulting from COX inhibition and the suppression of prostaglandin synthesis preclude the long-term use of NSAIDs for cancer chemoprevention. Furthermore, chemopreventive efficacy is incomplete and treatment often leads to the development of resistance. Identification of alternative NSAID targets and elucidation of the biochemical processes by which they inhibit tumor growth could lead to the development of safer and more efficacious drugs for cancer chemoprevention.
authors.affiliation: Department of Pharmacology and Toxicology, The University of Alabama at Birmingham , Birmingham, AL , USA.
authors.forename: Evrim
authors.initials: E
authors.lastname: Gurpinar
authors.forename: William E
authors.initials: WE
authors.lastname: Grizzle
authors.forename: Gary A
authors.initials: GA
authors.lastname: Piazza
keywords: NSAIDs; cancer; chemoprevention; colon; sulindac; targets